Neighbourhood socioeconomic status and overweight/obesity: a systematic review and meta-analysis of epidemiological studies
Generic metformin, also used to treat diabetes, is associated with utilization management tools in only 30% of ACA Marketplace plans, almost exclusively in the form of quantity limits
The SURPASS-4 trial examined the effects of tirzepatide, a dual GLP1 and GIP receptor agonist, on kidney outcomes in comparison to insulin glargine
393 These encouraging results have prompted two clinical trials, NCT03840005 (phase II) and NCT02967250 (phase I), which investigate the application of UDCA in PD patients
This allows them to bypass metabolism by hepatic enzymes such as CYPs or UDP-glucuronosyltransferases (UGTs)
What to track Weight is the most obvious metric, but it is also the most misleading when measured in isolation